These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7524496)

  • 1. Potent inhibition of insulin receptor dephosphorylation by a hexamer peptide containing the phosphotyrosyl mimetic F2Pmp.
    Burke TR; Kole HK; Roller PP
    Biochem Biophys Res Commun; 1994 Oct; 204(1):129-34. PubMed ID: 7524496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-O-(2-malonyl)tyrosine: a new phosphotyrosyl mimetic for the preparation of Src homology 2 domain inhibitory peptides.
    Ye B; Akamatsu M; Shoelson SE; Wolf G; Giorgetti-Peraldi S; Yan X; Roller PP; Burke TR
    J Med Chem; 1995 Oct; 38(21):4270-5. PubMed ID: 7473554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why is phosphonodifluoromethyl phenylalanine a more potent inhibitory moiety than phosphonomethyl phenylalanine toward protein-tyrosine phosphatases?
    Chen L; Wu L; Otaka A; Smyth MS; Roller PP; Burke TR; den Hertog J; Zhang ZY
    Biochem Biophys Res Commun; 1995 Nov; 216(3):976-84. PubMed ID: 7488220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein-tyrosine phosphatase inhibition by a peptide containing the phosphotyrosyl mimetic, L-O-malonyltyrosine.
    Kole HK; Akamatsu M; Ye B; Yan X; Barford D; Roller PP; Burke TR
    Biochem Biophys Res Commun; 1995 Apr; 209(3):817-22. PubMed ID: 7537500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonhydrolyzable phosphotyrosyl mimetics for the preparation of phosphatase-resistant SH2 domain inhibitors.
    Burke TR; Smyth MS; Otaka A; Nomizu M; Roller PP; Wolf G; Case R; Shoelson SE
    Biochemistry; 1994 May; 33(21):6490-4. PubMed ID: 7515682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporation of phosphotyrosyl mimetic 4-(phosphonodifluoromethyl)phenylalanine (F2Pmp) into signal transduction-directed peptides.
    Yao ZJ; Lee K; Burke TR
    Methods Mol Biol; 2005; 298():91-103. PubMed ID: 16044542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4'-O-[2-(2-fluoromalonyl)]-L-tyrosine: a phosphotyrosyl mimic for the preparation of signal transduction inhibitory peptides.
    Burke TR; Ye B; Akamatsu M; Ford H; Yan X; Kole HK; Wolf G; Shoelson SE; Roller PP
    J Med Chem; 1996 Mar; 39(5):1021-7. PubMed ID: 8676336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic peptide inhibitors of phosphatidylinositol 3-kinase p85 SH2 domain binding.
    Burke TR; Nomizu M; Otaka A; Smyth MS; Roller PP; Case RD; Wolf G; Shoelson SE
    Biochem Biophys Res Commun; 1994 Jun; 201(3):1148-53. PubMed ID: 8024556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phosphotyrosyl mimetic peptide reverses impairment of insulin-stimulated translocation of GLUT4 caused by overexpression of PTP1B in rat adipose cells.
    Chen H; Cong LN; Li Y; Yao ZJ; Wu L; Zhang ZY; Burke TR; Quon MJ
    Biochemistry; 1999 Jan; 38(1):384-9. PubMed ID: 9890920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enantioselective synthesis of (S)-3-carboxy-4-((carboxy)difluoromethyl)phenylalanine in protected form and its incorporation into a PTP-1B-directed tripeptide.
    Kang SU; Gao Y; Wu L; Zhang ZY; Burke TR
    Chem Biodivers; 2004 Apr; 1(4):626-33. PubMed ID: 17191873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific inhibition of insulin receptor dephosphorylation by a synthetic dodecapeptide containing sulfotyrosyl residues as phosphotyrosyl mimetic.
    Kole HK; Liotta AS; Garant MJ; Kole S; Bernier M
    Indian J Biochem Biophys; 1997; 34(1-2):50-5. PubMed ID: 9343928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Difluro(phosphono)methyl]phenylalanine-containing peptide inhibitors of protein tyrosine phosphatases.
    Desmarais S; Friesen RW; Zamboni R; Ramachandran C
    Biochem J; 1999 Jan; 337 ( Pt 2)(Pt 2):219-23. PubMed ID: 9882618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of phosphonodifluoromethyl phenylalanine (F2Pmp): a useful phosphotyrosyl mimetic.
    Burke TR
    Curr Top Med Chem; 2006; 6(14):1465-71. PubMed ID: 16918462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide probes containing a non-hydrolyzable phosphotyrosine-mimetic residue for enrichment of protein tyrosine phosphatases.
    Tsumagari K; Niinae T; Otaka A; Ishihama Y
    Proteomics; 2022 Feb; 22(4):e2100144. PubMed ID: 34714599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands.
    Yao ZJ; King CR; Cao T; Kelley J; Milne GW; Voigt JH; Burke TR
    J Med Chem; 1999 Jan; 42(1):25-35. PubMed ID: 9888830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-affinity binding determined by titration calorimetry using a high-affinity coupling ligand: a thermodynamic study of ligand binding to protein tyrosine phosphatase 1B.
    Zhang YL; Zhang ZY
    Anal Biochem; 1998 Aug; 261(2):139-48. PubMed ID: 9716416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The crystal structures of the SH2 domain of p56lck complexed with two phosphonopeptides suggest a gated peptide binding site.
    Mikol V; Baumann G; Keller TH; Manning U; Zurini MG
    J Mol Biol; 1995 Feb; 246(2):344-55. PubMed ID: 7532720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecule interactions with protein-tyrosine phosphatase PTP1B and their use in inhibitor design.
    Burke TR; Ye B; Yan X; Wang S; Jia Z; Chen L; Zhang ZY; Barford D
    Biochemistry; 1996 Dec; 35(50):15989-96. PubMed ID: 8973169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent inhibition of protein-tyrosine phosphatase by phosphotyrosine-mimic containing cyclic peptides.
    Akamatsu M; Roller PP; Chen L; Zhang ZY; Ye B; Burke TR
    Bioorg Med Chem; 1997 Jan; 5(1):157-63. PubMed ID: 9043667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of 3'-carboxy-containing tyrosine derivatives as a new class of phosphotyrosyl mimetics in the preparation of novel non-phosphorylated cyclic peptide inhibitors of the Grb2-SH2 domain.
    Song YL; Tan J; Luo XM; Long YQ
    Org Biomol Chem; 2006 Feb; 4(4):659-66. PubMed ID: 16467940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.